[go: up one dir, main page]

WO2006019105A1 - Fluorescent labeling agents - Google Patents

Fluorescent labeling agents Download PDF

Info

Publication number
WO2006019105A1
WO2006019105A1 PCT/JP2005/014983 JP2005014983W WO2006019105A1 WO 2006019105 A1 WO2006019105 A1 WO 2006019105A1 JP 2005014983 W JP2005014983 W JP 2005014983W WO 2006019105 A1 WO2006019105 A1 WO 2006019105A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
fluorescent labeling
labeling agent
fluorescent
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2005/014983
Other languages
French (fr)
Japanese (ja)
Inventor
Tetsuo Nagano
Yasuteru Urano
Tomoko Mineno
Tasuku Ueno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sekisui Medical Co Ltd
Original Assignee
Daiichi Pure Chemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pure Chemicals Co Ltd filed Critical Daiichi Pure Chemicals Co Ltd
Priority to JP2006531814A priority Critical patent/JP5068535B2/en
Publication of WO2006019105A1 publication Critical patent/WO2006019105A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B11/00Diaryl- or thriarylmethane dyes
    • C09B11/04Diaryl- or thriarylmethane dyes derived from triarylmethanes, i.e. central C-atom is substituted by amino, cyano, alkyl
    • C09B11/06Hydroxy derivatives of triarylmethanes in which at least one OH group is bound to an aryl nucleus and their ethers or esters
    • C09B11/08Phthaleins; Phenolphthaleins; Fluorescein
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/533Production of labelled immunochemicals with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label

Definitions

  • the present invention relates to a fluorescent labeling agent.
  • Fluorescence labeling is the detection of a target substance by combining a labeling agent such as an organic fluorescent dye with a biological substance that is the target substance, and utilizing the fluorescence properties such as excitation and fluorescence spectrum specific to the labeling agent. 'This is a method that enables quantification.
  • the fluorescent labeling agent should have a fluorescent group with strong fluorescence and a highly reactive active group (reactive functional group) that can react rapidly with the target biological substance. It is.
  • Fluorescein is a fluorescent dye having an absorption maximum of 492 nm and a fluorescence maximum of 515 nm, and is widely used as a parent nucleus of a fluorescent labeling agent with a high molecular yield of 0.85. Fluorescein is normally excited by a 488 nm argon laser and detected at 530 nm. Carboxyfluorescein is known as the most widely used fluorescent labeling agent to which this fluorescein is applied. This substance has a chemical structure in which a carboxyl group is introduced as a labeling site (reactive functional group) for binding to highly fluorescent fluorescein to proteins, etc. Are present (5-carboxyfluorescein and 6-carboxyfluorescein).
  • fluorescent labeling agents are often provided as succinimidyl esters or isothiocyanates for the purpose of modifying amino groups such as lysine residues in proteins.
  • the present inventors can further increase the sensitivity by optimizing the chemical structure of carboxyfluoresceins that have been widely used as fluorescent labeling agents from the viewpoint of photophysicochemistry. Research was conducted to develop a new fluorescent labeling agent.
  • the present inventors have found that the fluorescence quantum yield of carboxyfluorescein may decrease when it is converted to an ester or amide to label proteins using carboxyfluorescein. I found it. This may be due to photoinduced electron transfer.
  • R 4 each independently represents a hydrogen atom or a monovalent substituent, and at least one of them represents a reactive functional group that can be bonded to a labeled substance via a covalent bond
  • R 5 represents hydrogen.
  • R 6 and R 7 each independently represent a hydrogen atom or a halogen atom
  • R 8 represents a hydrogen atom, an alkyl carbo group, or an alkyl carbo group.
  • the fluorescent labeling agent R 5 is an alkyl group or an alkoxy group; the reactive functional groups, the fluorescent labeling agent is a carboxyl group or a reactive derivative thereof;
  • the fluorescent labeling agent in which the reactive functional group is an active ester group; the fluorescent labeling agent in which the labeling substance is a protein, nucleic acid, or lipid is provided.
  • the combination of Ri to R 5 is derived, for example, from the compound represented by the formula (I) after covalently bonding to the labeling substance. This is a combination in which the reduction potential of the benzene ring to which they are bonded is -2.1 V or less so that the residues are substantially highly fluorescent.
  • the present invention provides a method for fluorescently labeling a labeling target substance, which comprises the step of reacting the above fluorescent labeling agent with the labeling target substance.
  • the invention's effect [0009]
  • the fluorescent labeling agent of the present invention overcomes the decrease in fluorescence quantum yield due to labeling seen with carboxyfluorescein, and as a fluorescent labeling agent having a high quantum yield, protein or organic Useful for labeling compounds.
  • FIG. 1 is a graph showing an absorption spectrum of BSA modified with the fluorescent labeling agent of the present invention and a control carboxyfluorescein-SE.
  • FIG. 2 is a diagram showing the fluorescence spectrum (excitation wavelength: 490 nm) of BSA modified with the fluorescent labeling agent of the present invention and a control carboxyfluorescein-SE.
  • fluorescent labeling agent of the present invention is shown below.
  • a carboxyl group to be substituted on the benzene ring reacts with an amino group, a hydroxyl group, a thiol group, etc. present in the label target substance, whereby the label target substance can be fluorescently labeled.
  • each of the above compounds uses a carboxyl group on the benzene ring, and even if it is fluorescently labeled through a covalent bond such as an ester bond or an amide bond with the hydroxyl group-amino group of the label target substance. It has an excellent feature that the fluorescence intensity does not decrease and canoleboxoxif
  • the labeling agent may be a derivative of a carboxyl group on the benzene ring that can be bonded to the labeling substance via a covalent bond in the above compound.
  • the carboxyl group may be an acid neurogen. Or a mixed acid anhydride, or may form an active ester with nitro or halogen-substituted phenol, N-hydroxysuccinimide.
  • the carboxyl group that replaces the benzene ring is an active ester (for example, N-hydro A compound converted into xysuccinimidino estenole, p-nitropheneno estenole, pentafunololeorophenol ester, etc.) is preferred as the fluorescent labeling agent of the present invention.
  • an isocyanato group or an isothiocyanate group may be used as a functional group on the benzene ring that can be bonded to the labeling substance via a covalent bond.
  • Fluoroores and Their Amine— Reactive Derivatives 3 ⁇ 43 ⁇ 41 ⁇ (Thioto Reactive Probes), 5th Reagents for Reagents for Molecular Probes catalog (Handoook of Fluorescent Probes and Research Chemicals, Ninth Edition) Reactive functional groups described in Modifying Groups Other Than Tniols and A mines) can also be used.
  • an alkyl group or an alkoxy group is preferable, and a methyl group or a methoxy group can be used more preferably.
  • this new fluorescent labeling agent is advantageous from a synthetic point of view. That is, it is possible to obtain a single isomer with a limited substitution position of the force lpoxyl group in a high yield, and this point is also more useful than carboxyfluoresceins.
  • the fluorescent labeling agent of the present invention is a label for labeling substances (for example, various organic low molecules or organic polymer compounds in addition to biomolecules such as proteins, nucleic acids and lipids). It can be used for conversion.
  • the labeling method is not particularly limited, and can be performed according to the labeling method using carboxyfluorescein, which is a conventional fluorescent labeling agent.
  • tert-butyl ester 6 (271 mg, 1 mmol) was dissolved in tetrahydrofuran (20 mL) under an argon atmosphere. At -100 ° C, tert-butyllithium (1.48 M, 0.7 mL, 1 mmol) was slowly added and stirred at the same temperature for 30 minutes. To this solution was slowly added dropwise a solution of 3,6-bis- (tert-butyldimethylsila-loxy) -xanthen-9-one (91 mg, 0.2 mmol) in tetrahydrofuran (10 mL), and the container was aluminum. It was covered with foil and stirred for another hour at the same temperature. To the reaction solution, 2 N HC1 (5 mL) was stirred for 10 minutes. The reaction solution was diluted with saturated aqueous NaH 3 PO and extracted with ethyl acetate (3 X 15 mL).
  • tert-butyl ester 10 (287 mg, 1 mmol) was dissolved in tetrahydrofuran (20 mL) under an argon atmosphere. At -100 ° C, tert-butyllithium (1.48 M, 0.7 mL, 1 mmol) was slowly added and stirred at the same temperature for 30 minutes. In this solution, 3,6-bis- (tert- A solution of tildimethylsilyloxy) xanthen-9-one (91 mg, 0.2 mmol) in tetrahydrofuran (10 mL) was slowly added dropwise, the container was covered with aluminum foil, and the mixture was further stirred at the same temperature for 1 hour. To the reaction solution, 2 N HC1 (5 mL) was stirred for 10 minutes. The reaction solution was diluted with saturated aqueous NaH 3 PO and extracted with ethyl acetate (3 X 15 mL).
  • Pyrrolidine amide 14 (284 mg, 1 mmol) was dissolved in tetrahydrofuran (20 mL) in a well-dried container under an argon atmosphere. At -100 ° C, tert-butyllithium (1.48 M, 0.7 mL, 1 mmol) was slowly added and stirred at the same temperature for 30 minutes. To this solution was slowly added dropwise a solution of 3,6-bis- (tert-butyldimethylsila-loxy) -xanthen-9-one (91 mg, 0.2 mmol) in tetrahydrofuran (10 mL), and the container was covered with aluminum foil. The mixture was further stirred at the same temperature for 1 hour.
  • reaction solution 2 N HC1 (5 mL) was stirred for 10 minutes.
  • the reaction solution is diluted with saturated aqueous NaHPO solution, extracted with ethyl acetate (3 X 15 mL), and washed with saturated brine.
  • Example 6 Relationship between Fluorescence Quantum Yield of Compounds 11, 17, and 19, and 4-Methoxycarbo-fluorescein and Reduction Potential of Benzene Ring Site
  • Table 3 shows the relationship between the fluorescence quantum yields of compounds 11, 17, and 19, and 4-methoxycarbo-fluorescein and the reduction potential of the benzene ring moiety.
  • the reduction potential of the benzene ring moiety is a value measured in acetonitrile with A, B, and C, and in D aqueous solution with a saturated calomel electrode (SCE) as a reference electrode.
  • SCE saturated calomel electrode
  • the fluorescence quantum yield of compound 19 is high (0.673), compared to the fluorescence quantum yield (0.203) of 4-methoxycarbofluorescein.
  • the level of reduction potential at the benzene ring site of both compounds was similar. From these results, compounds with high electron density and which are not easily reduced are unlikely to cause photo-induced electron transfer (d-PeT) from the excited fluorophore (difficult to become a pet acceptor) and have high fluorescence quantum. This was considered to indicate the yield.
  • the reduction potentials of methyl ester of 4_carboxyl-sol and 3_carboxyl-anol were confirmed to be -2.54V and -2.34V, respectively. It was thought that it was less likely to be a PeT acceptor than the reduction potential of 2-methoxycarbo-naphthalene (C) at the benzene ring site of compound 19.
  • the fluorescent quantum yields of the esters of compounds 12 and 16 having boxyl-sole and 3-carboxyl-sole as the benzene ring moiety are 0.842 and 0.558, respectively, and the fluorescent quantum yield of 6-carboxyfluorescein methyl ester is Higher than rate. In this way, it was found that a combination of substituents that give a reduction potential to the benzene ring so as to be substantially high and fluorescent can be selected.
  • Compounds 12 and 16 are suitable as fluorescent labeling agents with high quantum yield.
  • Example 8 Fluorescence modification of BSA using the fluorescent labeling agent of the present invention
  • the fluorescent labeling agent of the present invention overcomes the decrease in the fluorescence quantum yield due to the labeling observed with carboxyfluorescein, and as a fluorescent labeling agent having a high quantum yield, proteins such as organic compounds Useful for labeling.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

Fluorescent labeling agents represented by the general formula (I): (I) wherein R1 to R4 are each independently hydrogen or a monovalent substituent, with the proviso that at least one of R1 to R4 is a reactive functional group capable of binding to a substance to be labeled through a covalent bond; R5 is hydrogen or a monovalent group exclusive of carboxy and sulfo; R6 and R7 are each independently hydrogen or halogeno; and R8 is hydrogen, alkylcarbonyl, or alkylcarbonyloxymethyl, with the proviso that R1 to R5 must be a combination which can give the benzene ring to which they are bonded such a low reduction potential that the compound represented by the general formula (I) can exhibit substantially high fluorescence in a state bound to the substrate to be labeled through a covalent bond.

Description

明 細 書  Specification

蛍光ラベル化剤  Fluorescent labeling agent

技術分野  Technical field

[0001] 本発明は蛍光ラベル化剤に関する。  [0001] The present invention relates to a fluorescent labeling agent.

背景技術  Background art

[0002] タンパク質や生理活性物質など微量の生体物質を高感度、高精度で検出'定量す ることはケミカルバイオロジーやバイオテクノロジーの発展における重要な研究課題 である。この目的のため、蛍光ラベルイ匕技術が汎用されている。蛍光ラベル化とは、 有機蛍光色素などラベル化剤を標的物質である生体物質と結合させ、ラベル化剤特 有の励起 ·蛍光スぺ外ル等の蛍光特性を利用することにより標的物質の検出'定量 を可能とする方法である。この目的のため、蛍光ラベル化剤には、強い蛍光を持つ蛍 光団と、標的物質である生体物質と迅速に反応できる反応性の高い活性基 (反応性 官能基)とを持つことが望まれる。  [0002] The detection and quantification of minute amounts of biological substances such as proteins and physiologically active substances with high sensitivity and high accuracy is an important research subject in the development of chemical biology and biotechnology. For this purpose, fluorescent labeling technology is widely used. Fluorescence labeling is the detection of a target substance by combining a labeling agent such as an organic fluorescent dye with a biological substance that is the target substance, and utilizing the fluorescence properties such as excitation and fluorescence spectrum specific to the labeling agent. 'This is a method that enables quantification. For this purpose, the fluorescent labeling agent should have a fluorescent group with strong fluorescence and a highly reactive active group (reactive functional group) that can react rapidly with the target biological substance. It is.

[0003] フルォレセインは吸収極大 492 nm、蛍光極大 515 nmを示す蛍光性色素であり、量 子収率も 0.85と高ぐ蛍光ラベル化剤の母核として汎用されている。フルォレセインは 、通常、 488 nmのアルゴンレーザーにて励起され、 530 nmにて検出される。このフル ォレセインを応用した最も汎用される蛍光ラベル化剤としてカルボキシフルォレセィ ンが知られている。この物質は、高い蛍光性のフルォレセインに対してタンパク質な どに結合させるためのラベルイ匕部位 (反応性官能基)としてカルボキシル基が導入さ れた化学構造を有しており、 2種の位置異性体 (5-カルボキシフルォレセイン及び 6- カルボキシフルォレセイン)が存在する。し力しながら、これらの 2つの異性体を分離 して合成することは困難であり、ほとんどの場合には混合物のまま蛍光ラベル化剤と して用いられている。また、蛍光ラベル化剤はタンパクのリシン残基などのアミノ基修 飾の目的のため、スクシンィミジルエステルやイソチオシァネート体として提供される ことも多い。

Figure imgf000004_0001
[0003] Fluorescein is a fluorescent dye having an absorption maximum of 492 nm and a fluorescence maximum of 515 nm, and is widely used as a parent nucleus of a fluorescent labeling agent with a high molecular yield of 0.85. Fluorescein is normally excited by a 488 nm argon laser and detected at 530 nm. Carboxyfluorescein is known as the most widely used fluorescent labeling agent to which this fluorescein is applied. This substance has a chemical structure in which a carboxyl group is introduced as a labeling site (reactive functional group) for binding to highly fluorescent fluorescein to proteins, etc. Are present (5-carboxyfluorescein and 6-carboxyfluorescein). However, it is difficult to separate and synthesize these two isomers, and in most cases they are used as fluorescent labeling agents in a mixture. In addition, fluorescent labeling agents are often provided as succinimidyl esters or isothiocyanates for the purpose of modifying amino groups such as lysine residues in proteins.
Figure imgf000004_0001

Fluorescein 5-Carboxyfluorescein (5CF) 6-Carboxyfluorescein (6CF)  Fluorescein 5-Carboxyfluorescein (5CF) 6-Carboxyfluorescein (6CF)

発明の開示  Disclosure of the invention

発明が解決しょうとする課題  Problems to be solved by the invention

[0004] 本発明者らは、これまで蛍光ラベル化剤として汎用されてきたカルボキシフルォレ セイン類の化学構造を光物理化学的観点から最適化することで、さらなる高感度化 を可能とする新規蛍光ラベル化剤を開発すべく研究を行なった。  [0004] The present inventors can further increase the sensitivity by optimizing the chemical structure of carboxyfluoresceins that have been widely used as fluorescent labeling agents from the viewpoint of photophysicochemistry. Research was conducted to develop a new fluorescent labeling agent.

本発明者らは、カルボキシフルォレセインを用いてタンパク質などをラベルイ匕するた めにエステル体やアミド体に変換すると、カルボキシフルォレセインの蛍光量子収率 が低下する場合があることを見いだした。これは光誘起電子移動によることが考えら れる。  The present inventors have found that the fluorescence quantum yield of carboxyfluorescein may decrease when it is converted to an ester or amide to label proteins using carboxyfluorescein. I found it. This may be due to photoinduced electron transfer.

[0005] 一方、本発明者らは、ごく最近、従来フルォレセインの蛍光特性に必須であると考 えられてきた 2-位のカルボキシル基は他の置換基に置き換えることが可能であること を見いだした(WO2004/005917)。そして、フルォレセインのカルボキシル基をメチル 基又はメトキシ基に置換したィ匕合物の蛍光特性は、フルォレセインと同様の励起 '蛍 光波長、蛍光量子収率を示すと!ヽぅ知見を得ることに成功した。  [0005] On the other hand, the present inventors have recently found that the 2-position carboxyl group, which has been considered to be essential for the fluorescence properties of fluorescein, can be replaced with other substituents. (WO2004 / 005917). The fluorescence properties of the compound in which the carboxyl group of fluorescein is substituted with a methyl group or a methoxy group show the same excitation wavelength and fluorescence quantum yield as fluorescein! did.

以上の知見を併せ、フルォレセインを蛍光団であるキサンテン部位とこれに直交す るベンゼン環部位に分けて考える手法を採用し、フルォレセインのベンゼン環部の 2 位のカルボキシル基をメチル基又はメトキシ基などに置換することにより、ベンゼン環 部位の電子密度を高め、励起蛍光団からの光誘起電子移動 (Donor-Excited Photoi nduced Electron Transfer; d-PeT)を起こしにくくし、カルボキシフルォレセインで見ら れたラベル化による蛍光量子収率の低下を克服した新規蛍光ラベル化剤を開発す ることに成功した。  Combined with the above findings, we adopted a method that considers fluorescein divided into a xanthene moiety, which is a fluorophore, and a benzene ring moiety perpendicular to this, and the carboxyl group at the 2-position of the benzene ring part of fluorescein is a methyl group or a methoxy group. To increase the electron density at the benzene ring site, making it less likely to cause photo-induced electron transfer (d-PeT) from the excited fluorophore, and is not observed with carboxyfluorescein. We succeeded in developing a novel fluorescent labeling agent that overcomes the decrease in fluorescence quantum yield due to improved labeling.

[0006] 本発明により、下記の式 (I): [化 2] [0006] According to the present invention, the following formula (I): [Chemical 2]

(

Figure imgf000005_0001
R4はそれぞれ独立に水素原子又は一価の置換基を示すが 、これらのうち少なくとも 1個は、被ラベル化物質に共有結合を介して結合可能な反 応性官能基を示し; R5は水素原子、カルボキシル基またはスルホン酸基以外の一価 の基を示し; R6及び R7はそれぞれ独立に水素原子又はハロゲン原子を示し; R8は水 素原子、アルキルカルボ-ル基、又はアルキルカルボ-ルォキシメチル基を示し、た だし、
Figure imgf000005_0002
R4、及び R5の組み合わせは、式 (I)で表される化合物が被ラベル 化物質に共有結合した後、実質的に高い蛍光性になるように、それらが結合するべ
Figure imgf000005_0003
、還元電位を与える組み合わせである)で表される蛍光ラベル化剤が 提供される。 (
Figure imgf000005_0001
R 4 each independently represents a hydrogen atom or a monovalent substituent, and at least one of them represents a reactive functional group that can be bonded to a labeled substance via a covalent bond; R 5 represents hydrogen. Represents a monovalent group other than an atom, a carboxyl group or a sulfonic acid group; R 6 and R 7 each independently represent a hydrogen atom or a halogen atom; R 8 represents a hydrogen atom, an alkyl carbo group, or an alkyl carbo group. -Represents a ruoxymethyl group, provided that
Figure imgf000005_0002
The combination of R 4 and R 5 should be bound so that the compound represented by formula (I) becomes substantially highly fluorescent after covalently binding to the labeling substance.
Figure imgf000005_0003
, A combination that gives a reduction potential).

[0007] 上記発明の好ましい態様によれば、 R5がアルキル基又はアルコキシ基である上記 蛍光ラベル化剤;該反応性官能基が、カルボキシル基又はその反応性誘導体である 上記蛍光ラベル化剤;該反応性官能基が活性エステル基である上記蛍光ラベルイ匕 剤;被ラベル化物質がタンパク質、核酸、又は脂質である上記蛍光ラベル化剤が提 供される。 [0007] According to a preferred embodiment of the invention, the fluorescent labeling agent R 5 is an alkyl group or an alkoxy group; the reactive functional groups, the fluorescent labeling agent is a carboxyl group or a reactive derivative thereof; The fluorescent labeling agent in which the reactive functional group is an active ester group; the fluorescent labeling agent in which the labeling substance is a protein, nucleic acid, or lipid is provided.

[0008] 式 (I)で表される化合物にお!、て、 Ri〜R5の組み合わせは、例えば、被ラベル化物 質に共有結合した後、式 (I)で表される化合物に由来する残基が実質的に高い蛍光 性になるように、それらが結合するベンゼン環の還元電位を- 2.1V以下にする組み合 わせである。 In the compound represented by the formula (I), the combination of Ri to R 5 is derived, for example, from the compound represented by the formula (I) after covalently bonding to the labeling substance. This is a combination in which the reduction potential of the benzene ring to which they are bonded is -2.1 V or less so that the residues are substantially highly fluorescent.

別の観点からは、被ラベルイ匕物質を蛍光ラベルイ匕する方法であって、上記の蛍光 ラベル化剤と被ラベルイ匕物質とを反応させる工程を含む方法が本発明により提供さ れる。  From another viewpoint, the present invention provides a method for fluorescently labeling a labeling target substance, which comprises the step of reacting the above fluorescent labeling agent with the labeling target substance.

発明の効果 [0009] 本発明の蛍光ラベル化剤は、カルボキシフルォレセインで見られたラベル化による 蛍光量子収率の低下を克服しており、高い量子収率を有する蛍光ラベル化剤として タンパク質又は有機化合物などのラベル化に有用である。 The invention's effect [0009] The fluorescent labeling agent of the present invention overcomes the decrease in fluorescence quantum yield due to labeling seen with carboxyfluorescein, and as a fluorescent labeling agent having a high quantum yield, protein or organic Useful for labeling compounds.

図面の簡単な説明  Brief Description of Drawings

[0010] [図 1]図 1は本発明の蛍光ラベル化剤及び対照のカルボキシフルォレセイン- SEによ り修飾された BSAの吸収スペクトルを示した図である。  FIG. 1 is a graph showing an absorption spectrum of BSA modified with the fluorescent labeling agent of the present invention and a control carboxyfluorescein-SE.

[図 2]図 2は本発明の蛍光ラベル化剤及び対照のカルボキシフルォレセイン- SEによ り修飾された BSAの蛍光スペクトル (励起波長: 490 nm)を示した図である。  FIG. 2 is a diagram showing the fluorescence spectrum (excitation wavelength: 490 nm) of BSA modified with the fluorescent labeling agent of the present invention and a control carboxyfluorescein-SE.

発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION

[0011] 本発明の蛍光ラベル化剤の代表例を以下に示す。これらの化合物においては、ベ ンゼン環に置換するカルボキシル基が被ラベルイ匕物質に存在するァミノ基、水酸基、 チオール基などと反応して、被ラベルイ匕物質を蛍光ラベルイ匕することができる。 [0011] Representative examples of the fluorescent labeling agent of the present invention are shown below. In these compounds, a carboxyl group to be substituted on the benzene ring reacts with an amino group, a hydroxyl group, a thiol group, etc. present in the label target substance, whereby the label target substance can be fluorescently labeled.

[化 3]  [Chemical 3]

Figure imgf000006_0001
特に、上記の各化合物は、ベンゼン環上のカルボキシル基を使用し、被ラベルイ匕 物質の水酸基ゃァミノ基との間でエステル結合又はアミド結合などの共有結合を介し て蛍光ラベルイ匕しても実質的に蛍光強度が低下しないという優れた特徴を有しており 、カノレボキシフ
Figure imgf000006_0001
In particular, each of the above compounds uses a carboxyl group on the benzene ring, and even if it is fluorescently labeled through a covalent bond such as an ester bond or an amide bond with the hydroxyl group-amino group of the label target substance. It has an excellent feature that the fluorescence intensity does not decrease and canoleboxoxif

ルォレセインに比べて標的物質の高感度なラベルイ匕が可能である。  Highly sensitive labeling of target substances is possible compared to lourescein.

[0012] ラベル化剤としては、上記の化合物において、被ラベル化物質に共有結合を介し て結合可能なベンゼン環上のカルボキシル基力 その誘導体であってもよぐ例えば 、カルボキシル基が酸ノヽロゲン化物又は混合酸無水物を形成してもよぐまた、ニトロ またはハロゲン置換フエノール、 N-ヒドロキシスクシンイミドと活性エステルを形成して もよい。特にベンゼン環に置換するカルボキシル基を活性エステル (例えば、 N-ヒドロ キシスクシンイミジノレエステノレ、 p-ニトロフエ二ノレエステノレ、ペンタフノレオロフェニノレエ ステルなど)に変換した化合物は本発明の蛍光ラベル化剤として好ましい。また、被 ラベル化物質に共有結合を介して結合可能なベンゼン環上の官能基として、例えば 、イソシアナ一ト基、イソチオシアナ一ト基を用いてもよい。さらに、モレキュラープロ一 ブス社のカタログ (Handoook of Fluorescent Probes and Research Chemicals, Ninth Edition)の ¾¾1皁 (Fluorophores and Their Amine— Reactive Derivatives)、第 2皁 (Thi oト Reactive Probes)第5享(Reagents for Modifying Groups Other Than Tniols and A mines)に記載された反応性官能基を用いることもできる。 [0012] The labeling agent may be a derivative of a carboxyl group on the benzene ring that can be bonded to the labeling substance via a covalent bond in the above compound. For example, the carboxyl group may be an acid neurogen. Or a mixed acid anhydride, or may form an active ester with nitro or halogen-substituted phenol, N-hydroxysuccinimide. In particular, the carboxyl group that replaces the benzene ring is an active ester (for example, N-hydro A compound converted into xysuccinimidino estenole, p-nitropheneno estenole, pentafunololeorophenol ester, etc.) is preferred as the fluorescent labeling agent of the present invention. Further, for example, an isocyanato group or an isothiocyanate group may be used as a functional group on the benzene ring that can be bonded to the labeling substance via a covalent bond. In addition, Fluoroores and Their Amine— Reactive Derivatives, ¾¾1 皁 (Thioto Reactive Probes), 5th Reagents for Reagents for Molecular Probes catalog (Handoook of Fluorescent Probes and Research Chemicals, Ninth Edition) Reactive functional groups described in Modifying Groups Other Than Tniols and A mines) can also be used.

ベンゼン環上の 2位の置換基としては、例えば、アルキル基又はアルコキシ基が好 ましぐより好ましくはメチル基又はメトキシ基を用いることができる。  As the substituent at the 2-position on the benzene ring, for example, an alkyl group or an alkoxy group is preferable, and a methyl group or a methoxy group can be used more preferably.

以下に示すとおり、従来のカルボキシフルォレセインを水酸基に対する蛍光ラベル ィ匕剤として使用すると顕著な蛍光量子収率の減少が観測されるが、本発明の化合物 12を蛍光ラベル化剤として用いた場合には、ラベルイ匕後にも高い量子収率を保って いる。  As shown below, when a conventional carboxyfluorescein is used as a fluorescent labeling agent for a hydroxyl group, a remarkable decrease in the fluorescence quantum yield is observed, but the compound 12 of the present invention was used as a fluorescent labeling agent. In some cases, a high quantum yield is maintained after labeling.

[化 4] [Chemical 4]

Figure imgf000007_0001
Figure imgf000007_0001

6CF 6CF-Ester  6CF 6CF-Ester

φ=0.87 φ=0.20 さらに、この新しい蛍光ラベル化剤は合成的観点からも有利である。すなわち、力 ルポキシル基の置換位置が限定された単一の異性体を高収率で得ることが可能で あり、この点に置いてもカルボキシフルォレセイン類に比べて有用性が高い。  φ = 0.87 φ = 0.20 Furthermore, this new fluorescent labeling agent is advantageous from a synthetic point of view. That is, it is possible to obtain a single isomer with a limited substitution position of the force lpoxyl group in a high yield, and this point is also more useful than carboxyfluoresceins.

本発明の蛍光ラベル化剤は、被ラベルイ匕物質 (例えば、タンパク質、核酸、脂質類 などの生体分子のほか、各種の有機低分子又は有機高分子化合物など)のラベル 化に用いることができる。ラベルイ匕の方法は特に限定されず、従来の蛍光ラベル化 剤であるカルボキシフルォレセインなどを用いたラベルイ匕の方法に準じて行なうこと が可能である。 The fluorescent labeling agent of the present invention is a label for labeling substances (for example, various organic low molecules or organic polymer compounds in addition to biomolecules such as proteins, nucleic acids and lipids). It can be used for conversion. The labeling method is not particularly limited, and can be performed according to the labeling method using carboxyfluorescein, which is a conventional fluorescent labeling agent.

実施例 Example

以下、実施例により本発明をさらに具体的に説明するが、本発明の範囲は下記の 実施例に限定されることはない。  EXAMPLES Hereinafter, the present invention will be described more specifically with reference to examples. However, the scope of the present invention is not limited to the following examples.

例 1:本発明の蛍光ラベル化剤の製造 Example 1: Production of the fluorescent labeling agent of the present invention

<スキーム 1 > <Scheme 1>

[化 5] [Chemical 5]

Figure imgf000008_0001
Figure imgf000008_0001

(スキーム中、 Meはメチル基、 は tert-ブチル基を示す。以下同様である。 ) (A)3-ブロモ -4-メチル安息香酸 tert-ブチルエステル(2) (In the scheme, Me represents a methyl group, and represents a tert-butyl group. The same shall apply hereinafter.) (A) 3-bromo-4-methylbenzoic acid tert-butyl ester (2)

よく乾燥した容器に 3-ブロモ -4-メチル安息香酸(1) (430 mg, 2 mmol)を tert-ブタノ ール(10 mL)に溶かし、アルゴン雰囲気下で Boc 0 (Boc=tert-ブトキシカルボ-ル, 0  Dissolve 3-bromo-4-methylbenzoic acid (1) (430 mg, 2 mmol) in tert-butanol (10 mL) in a well-dried container and add Boc 0 (Boc = tert-butoxycarbo) under an argon atmosphere. -Le, 0

2  2

.46 mL, 2 mmol)とジメチルァミノピリジン(DMAP, 73 mg, 0.6 mmol)をカ卩えた。 40°Cに て撹拌しつつオーバーナイトで反応させた。反応溶液を水で希釈した後、酢酸ェチ エ / :- 邈彔 '¾ ^ - ε- rci i- κα) [8ioo] .46 mL, 2 mmol) and dimethylaminopyridine (DMAP, 73 mg, 0.6 mmol) were added. The reaction was carried out overnight with stirring at 40 ° C. After diluting the reaction solution with water, D /:-邈 彔 '¾ ^-ε- rci i- κα) [8ioo]

·ΐ060" ^ε punoj O260" ^S Ο Η D ^ ορο +[Η+ ] (S -IS3 · Ϊ́060 "^ ε punoj O260" ^ S Ο Η D ^ ορο + [Η +] (S -IS3

) S Η '(HS ' ΐ0 '{Hf 'ω) 9- 8Γ9 '(0·6 = f 'ΗΖ 'Ρ) 86·9 '(ε·8 = f 'Ηΐ 'Ρ) WL ) S Η '(HS' ΐ0 '(Hf' ω) 9-8Γ9 '(0 ・ 6 = f' ΗΖ 'Ρ) 86 · 9' (ε ・ 8 = f 'Ηΐ' Ρ) WL

'(9·ΐ = [ 'Ηΐ 'Ρ) Ϊ8"Ζ '(Ζ·ΐ '6"Ζ = [ 'Ηΐ 'ΡΡ) 80·8 9 ( OS 'ζ 00S) Η醒 Ητ '(9 · ΐ = [' Ηΐ 'Ρ) Ϊ8 "Ζ' (Ζ · ΐ '6" Ζ = [' Ηΐ 'ΡΡ) 80 · 8 9 (OS' ζ 00S) Wake up Η τ

。 (%86 ¾τ) §ω is ^^ )^^^ ((2;8)へ (一 . (% 86 ¾τ) §ω is ^^) ^^^ ((2 ; 8)

/ベ !^ :瀚缀 ffi缀)つ Hエ^— ^:^^ム!^ / f 、¾¾ ί ^ / Be! ^ : 瀚 缀 ffi 缀) つ Het ^ — ^: ^^ mu! ^ / F, ¾¾ ί ^

Ι Ι

Figure imgf000009_0001
Figure imgf000009_0001

^ ) TOO] ^) TOO]

•SISrSO punoj '9 rS0 O H つ Ρ。 。 +[H+ ] (S -IS3) S HH '(H6 's) 8 • SISrSO punoj '9 rS0 OH. . + [H +] (S -IS3) S HH '(H6' s ) 8

S'l '(HS 's) 0Z-9-Z9"9 '(0·6 = f 'HS 'Ρ) 20"Z '(ΐ·8 = f Ήΐ 'Ρ) 6S'Z '(8 •ΐ = ΓΗΐ 'Ρ) 08"Ζ '(8·ΐ 'ΐ·8 = ΓΗΐ 'ΡΡ) 0Γ8 9 ( 'ζ 00S) Η醒 Ητ S'l '(HS' s) 0Z-9-Z9 "9 '(0 · 6 = f' HS 'Ρ) 20"Z' (ΐ · 8 = f Ήΐ 'Ρ) 6S'Z' (8 • ΐ = ΓΗΐ 'Ρ) 08 "Ζ' (8 · ΐ 'ΐ · 8 = ΓΗΐ' ΡΡ) 0Γ8 9 (' ζ 00S) Awakening Η τ

。 ¾¾(%S6 ¾τ) §ω 9

Figure imgf000009_0002
、つ(ΐ:6= /. ¾¾ (% S6 ¾τ) §ω 9
Figure imgf000009_0002
, One (ΐ: 6 = /

— ^ /ベ^ /!^ :瀚缀 ffi缀) 慰エ^—^:^^ム!^ / f 、¾¾ — ^ / Be ^ /! ^: 瀚 缀 ffi 缀) joy e ^ — ^: ^^ mu! ^ / F, ¾¾

¾ 辛爵 瀚缀斜单 i^^^^os^N氺雜ェつ ¾ ^氺^ 靱  ¾ 爵 单 斜 单 i ^^^^ os ^ N 氺 雜 etsu ¾ ^ 氺 ^ Tough

エ^ Π111 eixs) ェ邈 、 ·Π 缀氺 od Η¾Να^¾ ¾¾¾¾ίΗ。 ·Π

Figure imgf000009_0003
、ェ 醫D Π 111 eixs) 邈, Π 缀 氺 od Η¾Να ^ ¾ ¾¾¾¾ίΗ. · Π
Figure imgf000009_0003

、 / マ - / ¾醬 、つ止縱; C)> ^ (τιι Οΐ) ^ ^^Q) (ΐο , / Ma-/ ¾ 醬, Stopping; C)> ^ (τιι Οΐ) ^ ^^ Q) (ΐο

UIUI z'O 'Sui 16)ベ - 6-べ べ ^ (^^ / ^ ^ :- - 9 コ5 继缀 °:·Πφί ί ¾^^ 0ε"¾^ίΤ6)>^Φ¾αο111111 ΐ Ζ 'マ ^ (Η,UIUI z'O 'Sui 16) Be-6-Begin ^ (^^ / ^ ^:--9 Co 5 继 缀 °: · Πφί ί ¾ ^^ 0ε "¾ ^ ίΤ6)> ^ Φ¾α ο111111 ΐ Ζ' Ma ^ (Η,

Figure imgf000009_0004
Figure imgf000009_0004

douiui τ 'Sin HZ) Ζ:# エ ^ :- 止^蹈 べ コ)醬兹 つ 1ί¾>Τ  douiui τ 'Sin HZ) Ζ : # D ^:-Stop ^ 蹈 Beco) 醬 兹 つ 1ί¾> Τ

s^^Ke) [9 TOO] s ^^ Ke) [9 TOO]

•(H6 <s) 8S'I '(HS 's) ZVZ (Γ8 = f 'HI 'P) 9 • (H6 <s ) 8S'I '(HS' s) ZVZ (Γ8 = f 'HI' P) 9

Z'L '(Ζ·ΐ '6"Ζ = f 'Ηΐ 'ΡΡ) Ϊ8"Ζ '(Ζ·ΐ = f 'Ηΐ 'Ρ) 2Γ8 9 ODOD '^Η 00S) WiH Ητ Z'L '(Ζ · ΐ' 6 "Ζ = f 'Ηΐ' ΡΡ) Ϊ8" Ζ '(Ζ · ΐ = f' Ηΐ 'Ρ) 2Γ8 9 ODOD' ^ Η 00S) WiH Η τ

。 %ΐ9 ? §ω τεε z -^^m^ 、つ(σ:6) ェ邈 4§/ベ ^ ^ 萆。 ^

Figure imgf000009_0005
ΟΪ χε) / . % ΐ9? §Ω τεε z-^^ m ^, (σ: 6) 邈 4§ / Be ^ ^ 萆. ^
Figure imgf000009_0005
ΟΪ χε) /

C86M0/S00Zdf/X3d L S0T610/900Z OAV よく乾燥した容器に 4-ブロモ -3-メチル安息香酸(5) (430 mg, 2 mmol)を tert-ブタノ ール(10 mL)に溶かし、アルゴン雰囲気下で Boc 0 (0.46 mL, 2 mmol)と DMAP (73 C86M0 / S00Zdf / X3d L S0T610 / 900Z OAV Dissolve 4-bromo-3-methylbenzoic acid (5) (430 mg, 2 mmol) in tert-butanol (10 mL) in a well-dried container and boc 0 (0.46 mL, 2 mmol) under argon. And DMAP (73

2  2

mg, 0.6 mmol)を加えた。 40 °Cにて撹拌しつつオーバーナイトで反応させた。反応溶 媒を水で希釈した後、酢酸ェチル (3 X 10 mL)にて抽出し、水、飽和食塩水で洗浄し て無水 Na SOで乾燥させた。有機溶媒を留去し、得られた残渣をシリカゲルカラムに  mg, 0.6 mmol) was added. The reaction was carried out overnight with stirring at 40 ° C. The reaction solvent was diluted with water, extracted with ethyl acetate (3 × 10 mL), washed with water and saturated brine, and dried over anhydrous Na 2 SO 4. The organic solvent was distilled off and the resulting residue was applied to a silica gel column.

2 4  twenty four

て精製 (溶出溶媒:へキサン/酢酸ェチル(9:1))し、無色の油性化合物 6 342 mg (収 率 63%)を得た。  Purification (elution solvent: hexane / ethyl acetate (9: 1)) gave colorless oily compound 6 342 mg (yield 63%).

JH NMR (300 MHz, CDC1 ) δ 7.83 (d, 1Η, J = 2.0), 7.64 (dd, 1H, J = 8.3, 2.0), 7.5 J H NMR (300 MHz, CDC1) δ 7.83 (d, 1Η, J = 2.0), 7.64 (dd, 1H, J = 8.3, 2.0), 7.5

3  Three

6 (d, 1H, J = 8.3) 2.43 (s, 3H), 1.58 (s, 9H).  6 (d, 1H, J = 8.3) 2.43 (s, 3H), 1.58 (s, 9H).

[0019] (E)化合物 7 [0019] (E) Compound 7

よく乾燥した容器にアルゴン雰囲気下 tert-ブチルエステル体 6 (271 mg, 1 mmol) をテトラヒドロフラン(20 mL)に溶かした。 -100 °Cにて、 tert-ブチルリチウム(1.48 M, 0.7 mL, 1 mmol)をゆっくり加え 30分間同温で撹拌した。この溶液に 3,6-ビス- (tert-ブ チルジメチルシラ-ルォキシ)-キサンテン- 9-オン(91 mg, 0.2 mmol)のテトラヒドロフ ラン(10 mL)溶液をゆっくりと滴下し、容器をアルミニウムホイルで覆って、さらに 1時 間同温で撹拌した。反応溶液に 2 N HC1 (5 mL)をカ卩ぇ 10分間撹拌した。反応溶液を 飽和 NaH PO水溶液で希釈した後、酢酸ェチル(3 X 15 mL)にて抽出し、飽和食塩  In a well-dried container, tert-butyl ester 6 (271 mg, 1 mmol) was dissolved in tetrahydrofuran (20 mL) under an argon atmosphere. At -100 ° C, tert-butyllithium (1.48 M, 0.7 mL, 1 mmol) was slowly added and stirred at the same temperature for 30 minutes. To this solution was slowly added dropwise a solution of 3,6-bis- (tert-butyldimethylsila-loxy) -xanthen-9-one (91 mg, 0.2 mmol) in tetrahydrofuran (10 mL), and the container was aluminum. It was covered with foil and stirred for another hour at the same temperature. To the reaction solution, 2 N HC1 (5 mL) was stirred for 10 minutes. The reaction solution was diluted with saturated aqueous NaH 3 PO and extracted with ethyl acetate (3 X 15 mL).

2 4  twenty four

水で洗浄して無水 Na SOで乾燥させた。有機溶媒を留去し、得られた残渣をシリカ  Washed with water and dried over anhydrous Na 2 SO 4. The organic solvent was distilled off, and the resulting residue was

2 4  twenty four

ゲルクロマトグラフィーにて精製 (溶出溶媒:ジクロルメタン/メタノール(9:1))し、ォレ ンジ色の固体状の化合物 7 68 mg (収率 85%)を得た。  Purification by gel chromatography (elution solvent: dichloromethane / methanol (9: 1)) gave orange solid 768 mg (yield 85%).

1H NMR (300 MHz,メタノール— d ) δ 8.05 (s, 1H), 8.01 (d, 1H, J = 8.1), 7.36 (d, 1  1H NMR (300 MHz, methanol—d) δ 8.05 (s, 1H), 8.01 (d, 1H, J = 8.1), 7.36 (d, 1

4  Four

H, J = 7.9), 7.03 (d, 2H, J = 9.2), 6.68-6.71 (m, 4H), 2.12 (s, 3H), 1.65 (s, 9H); HR MS (ESI-MS) [M+H]+ calcd for C H O 403.1546, found 403.1501. H, J = 7.9), 7.03 (d, 2H, J = 9.2), 6.68-6.71 (m, 4H), 2.12 (s, 3H), 1.65 (s, 9H); HR MS (ESI-MS) (M + H] + calcd for CHO 403.1546, found 403.1501.

25 23 5  25 23 5

[0020] (F)化合物 8  [0020] (F) Compound 8

よく乾燥した容器に化合物 7 (60 mg, 0.15 mmol)をトリフルォロ酢酸/ジクロルメタン( 1:1, 10 mL)に溶かし、アルゴン雰囲気下 1時間室温で撹拌した。有機溶媒を留去し、 得られた残渣をシリカゲルクロマトグラフィーにて精製 (溶出溶媒:ジクロルメタン/メタ ノール(8:2))し、オレンジ色の固体状の化合物 8 49 mg (収率 94%)を得た。 H NMR (300 MHz, DMSO- d ) δ 8.05 (s, IH), 7.98 (d, IH, J = 8.0), 7.43 (d, IH, JCompound 7 (60 mg, 0.15 mmol) was dissolved in trifluoroacetic acid / dichloromethane (1: 1, 10 mL) in a well-dried container and stirred at room temperature for 1 hour under an argon atmosphere. The organic solvent was distilled off, and the resulting residue was purified by silica gel chromatography (elution solvent: dichloromethane / methanol (8: 2)) to give an orange solid compound 8 49 mg (yield 94%) Got. H NMR (300 MHz, DMSO- d) δ 8.05 (s, IH), 7.98 (d, IH, J = 8.0), 7.43 (d, IH, J

6 6

= 7.9), 6.96 (d, 2H, J = 9.2), 6.77-6.73 (m, 4H), 2.07 (s, 3H); HRMS (ESト MS) [M+ H]+ calcd for C H O 347.0920, found 347.0897.  = 7.9), 6.96 (d, 2H, J = 9.2), 6.77-6.73 (m, 4H), 2.07 (s, 3H); HRMS (ES to MS) [M + H] + calcd for CHO 347.0920, found 347.0897.

21 15 5  21 15 5

例 2 :蛍光特性 Example 2: Fluorescence characteristics

各化合物の量子収率は、 490 nmにおける吸光度が 0.02以下となるように、 pH 7.4 (6 CF類については pH 9.0)の 0.1Mリン酸緩衝液に溶解し、 0.1N NaOH水溶液中のフ ルォレセインを対照(蛍光量子収率 = 0.85)として、相対法により決定した。  The quantum yield of each compound is dissolved in 0.1M phosphate buffer at pH 7.4 (pH 9.0 for 6CFs) so that the absorbance at 490 nm is 0.02 or less, and fluorescein in 0.1N NaOH aqueous solution. Was determined by a relative method as a control (fluorescence quantum yield = 0.85).

[表 1] [table 1]

Figure imgf000011_0001
例 3 :本発明の蛍光ラベル化剤の製造
Figure imgf000011_0001
Example 3: Production of fluorescent labeling agent of the present invention

<スキーム 2> <Scheme 2>

[化 6] [Chemical 6]

Figure imgf000012_0001
Figure imgf000012_0001

Figure imgf000012_0002
Figure imgf000012_0002

Figure imgf000012_0003
Figure imgf000012_0003

17  17

[0023] (A)3-ブロモ -4-メトキシ安息香酸 tert-ブチルエステル (10)  [0023] (A) 3-bromo-4-methoxybenzoic acid tert-butyl ester (10)

よく乾燥した容器に 3-ブロモ -4-メトキシ安息香酸 (9) (462 mg, 2 mmol)を tert-ブタノ ール(10 mL)に溶かし、アルゴン雰囲気下で Boc 0 (0.46 mL, 2 mmol)と DMAP (73  Dissolve 3-bromo-4-methoxybenzoic acid (9) (462 mg, 2 mmol) in tert-butanol (10 mL) in a well-dried container and boc 0 (0.46 mL, 2 mmol) under an argon atmosphere. And DMAP (73

2  2

mg, 0.6 mmol)をカ卩えた。撹拌しつつ 10時間還流し反応させた。反応溶液を水で希釈 した後、酢酸ェチル (3 X 10 mL)にて抽出し、水、飽和食塩水で洗浄して無水 Na SO  mg, 0.6 mmol). The mixture was refluxed for 10 hours with stirring. The reaction solution was diluted with water, extracted with ethyl acetate (3 X 10 mL), washed with water and saturated brine, and dried over anhydrous Na 2 SO 4.

2 4 で乾燥させた。有機溶媒を留去し、得られた残渣をシリカゲルクロマトグラフィーにて 精製 (溶出溶媒:へキサン/酢酸ェチル(9:1))し、白色の固体状の化合物 10 356 mg (収率 62%)を得た。  2 4 dried. The organic solvent was distilled off, and the resulting residue was purified by silica gel chromatography (elution solvent: hexane / ethyl acetate (9: 1)) to give a white solid compound 10 356 mg (yield 62%) Got.

JH NMR (300 MHz, CDCl ) δ 8.15 (d, IH, J = 2.0), 7.93 (dd, IH, J = 8.6, 2.0), 6.8 J H NMR (300 MHz, CDCl) δ 8.15 (d, IH, J = 2.0), 7.93 (dd, IH, J = 8.6, 2.0), 6.8

3  Three

9 (d, IH, J = 8.6) 3.94 (s, 3H), 1.58 (s, 9H).  9 (d, IH, J = 8.6) 3.94 (s, 3H), 1.58 (s, 9H).

[0024] (B)化合物 11 [0024] (B) Compound 11

よく乾燥した容器にアルゴン雰囲気下 tert-ブチルエステル体 10 (287 mg, 1 mmol) をテトラヒドロフラン(20 mL)に溶かした。 -100 °Cにて、 tert-ブチルリチウム(1.48 M, 0.7 mL, 1 mmol)をゆっくり加え 30分間同温で撹拌した。この溶液に 3,6-ビス- (tert-ブ チルジメチルシリルォキシ)キサンテン- 9-オン(91 mg, 0.2 mmol)のテトラヒドロフラン (10 mL)溶液をゆっくりと滴下し、容器をアルミニウムホイルで覆って、さらに 1時間同 温で撹拌した。反応溶液に 2 N HC1 (5 mL)をカ卩ぇ 10分間撹拌した。反応溶液を飽和 NaH PO水溶液で希釈した後、酢酸ェチル(3 X 15 mL)にて抽出し、飽和食塩水でIn a well-dried container, tert-butyl ester 10 (287 mg, 1 mmol) was dissolved in tetrahydrofuran (20 mL) under an argon atmosphere. At -100 ° C, tert-butyllithium (1.48 M, 0.7 mL, 1 mmol) was slowly added and stirred at the same temperature for 30 minutes. In this solution, 3,6-bis- (tert- A solution of tildimethylsilyloxy) xanthen-9-one (91 mg, 0.2 mmol) in tetrahydrofuran (10 mL) was slowly added dropwise, the container was covered with aluminum foil, and the mixture was further stirred at the same temperature for 1 hour. To the reaction solution, 2 N HC1 (5 mL) was stirred for 10 minutes. The reaction solution was diluted with saturated aqueous NaH 3 PO and extracted with ethyl acetate (3 X 15 mL).

2 4 twenty four

洗浄して無水 Na SOで乾燥させた。有機溶媒を留去し、得られた残渣をシリカゲルク  Washed and dried over anhydrous Na 2 SO 4. The organic solvent was distilled off, and the resulting residue was

2 4  twenty four

口マトグラフィ一にて精製 (溶出溶媒:ジクロルメタン/メタノール(9:1))し、オレンジ色 の固体状の化合物 11 48 mg (収率 57%)を得た。  Purification by oral chromatography (elution solvent: dichloromethane / methanol (9: 1)) gave 48 mg of orange solid compound 11 (yield 57%).

JH NMR (300 MHz,メタノール— d ) δ 8.24 (dd, 1Η, J = 8.8, 2.2), 7.82 (d, 1H, J = 2. J H NMR (300 MHz, methanol—d) δ 8.24 (dd, 1Η, J = 8.8, 2.2), 7.82 (d, 1H, J = 2.

4  Four

2), 7.35 (d, 1H, J = 8.8), 7.13 (d, 2H, J = 9.3), 6.74-6.70 (m, 4H), 3.82 (s, 3H), 1.5 8 (s, 9H); HRMS (ESト MS) [M+H]+ calcd for C H O 419.1495, found 419.1461. 2), 7.35 (d, 1H, J = 8.8), 7.13 (d, 2H, J = 9.3), 6.74-6.70 (m, 4H), 3.82 (s, 3H), 1.5 8 (s, 9H); HRMS (ES MS) [M + H] + calcd for CHO 419.1495, found 419.1461.

25 23 6  25 23 6

[0025] (C)化合物 12  [0025] (C) Compound 12

よく乾燥した容器に化合物 11 (63 mg, 0.15 mmol)をトリフルォロ酢酸/ジクロルメタン (1:1, 10 mL)に溶かし、アルゴン雰囲気下 1時間室温で撹拌した。有機溶媒を留去し 、得られた残渣をシリカゲルクロマトグラフィーにて精製 (溶出溶媒:ジクロルメタン/メ タノール(8:2))し、オレンジ色の固体状の化合物 12 45 mg (収率 83%)を得た。  Compound 11 (63 mg, 0.15 mmol) was dissolved in trifluoroacetic acid / dichloromethane (1: 1, 10 mL) in a well-dried container and stirred at room temperature for 1 hour in an argon atmosphere. The organic solvent was distilled off, and the resulting residue was purified by silica gel chromatography (elution solvent: dichloromethane / methanol (8: 2)) to give orange solid compound 12 45 mg (yield 83%) Got.

JH NMR (300 MHz, DMSO— d ) δ 8.20 (dd, 1H, J = 8.8, 2.2), 7.82 (d, 1H, J = 2.0),  JH NMR (300 MHz, DMSO— d) δ 8.20 (dd, 1H, J = 8.8, 2.2), 7.82 (d, 1H, J = 2.0),

6  6

7.43 (d, 1H, J = 8.8), 7.09 (d, 2H, J = 9.7), 6.76-6.73 (m, 4H), 3.78 (s, 3H); HRMS (ESI— MS) [M+H]+ calcd for C H O 363.0869, found 363.0840. 7.43 (d, 1H, J = 8.8), 7.09 (d, 2H, J = 9.7), 6.76-6.73 (m, 4H), 3.78 (s, 3H); HRMS (ESI— MS) [M + H] + calcd for CHO 363.0869, found 363.0840.

21 15 6  21 15 6

[0026] (D)化合物 14  [0026] (D) Compound 14

よく乾燥した容器に 4-ブロモ -3-メトキシ安息香酸 (13) (462 mg, 2 mmol)をジメチル ホルムアミド (10 mL)に溶かし、アルゴン雰囲気下でカルボジイミド(CDI, 486 mg, 3 m mol)、 DMAP (367 mg, 3 mmol),ピロリジン(0.33 mL, 4 mmol)をカ卩えた。室温で撹拌 しつつオーバーナイトで反応させた。反応溶液を水で希釈した後、酢酸ェチル (3 X 1 0 mL)にて抽出し、水、飽和食塩水で洗浄して無水 Na SOで乾燥させた。有機溶媒  In a well-dried container, 4-bromo-3-methoxybenzoic acid (13) (462 mg, 2 mmol) is dissolved in dimethylformamide (10 mL), and carbodiimide (CDI, 486 mg, 3 mmol), DMAP (367 mg, 3 mmol) and pyrrolidine (0.33 mL, 4 mmol) were added. The reaction was carried out overnight with stirring at room temperature. The reaction solution was diluted with water, extracted with ethyl acetate (3 × 10 mL), washed with water and saturated brine, and dried over anhydrous Na 2 SO 4. Organic solvent

2 4  twenty four

を留去し、得られた残渣をシリカゲルクロマトグラフィーにて精製 (溶出溶媒:へキサン /酢酸ェチル (2:1 to 1:1))し、白色の固体状の化合物 14 488 mg (収率 86%)を得た。 JH NMR (300 MHz, CDC1 ) δ 7.40 (d, 1H, J = 8.1), 6.96 (d, 1H, J =1.7), 6.83 (dd,  The residue obtained was purified by silica gel chromatography (elution solvent: hexane / ethyl acetate (2: 1 to 1: 1)), and white solid compound 14 488 mg (yield 86 %). JH NMR (300 MHz, CDC1) δ 7.40 (d, 1H, J = 8.1), 6.96 (d, 1H, J = 1.7), 6.83 (dd,

3  Three

1H, J = 8.0, 1.8) 3.77(s, 3H), 3.47 (t, 2H, J = 6.6), 3.28 (t, 2H, J = 6.4), 1.86—1.71 ( m, 4H). 1H, J = 8.0, 1.8) 3.77 (s, 3H), 3.47 (t, 2H, J = 6.6), 3.28 (t, 2H, J = 6.4), 1.86—1.71 ( m, 4H).

[0027] (E)化合物 15 [0027] (E) Compound 15

よく乾燥した容器にアルゴン雰囲気下ピロリジンアミド 14 (284 mg, 1 mmol)をテトラ ヒドロフラン(20 mL)に溶かした。 -100 °Cにて、 tert-ブチルリチウム(1.48 M, 0.7 mL, 1 mmol)をゆっくり加え 30分間同温で撹拌した。この溶液に 3,6-ビス- (tert-ブチルジ メチルシラ-ルォキシ)-キサンテン- 9-オン(91 mg, 0.2 mmol)のテトラヒドロフラン(1 0 mL)溶液をゆっくりと滴下し、容器をアルミニウムホイルで覆って、さらに 1時間同温 で撹拌した。反応溶液に 2 N HC1 (5 mL)をカ卩ぇ 10分間撹拌した。反応溶液を飽和 Na H PO水溶液で希釈した後、酢酸ェチル (3 X 15 mL)にて抽出し、飽和食塩水で洗 Pyrrolidine amide 14 (284 mg, 1 mmol) was dissolved in tetrahydrofuran (20 mL) in a well-dried container under an argon atmosphere. At -100 ° C, tert-butyllithium (1.48 M, 0.7 mL, 1 mmol) was slowly added and stirred at the same temperature for 30 minutes. To this solution was slowly added dropwise a solution of 3,6-bis- (tert-butyldimethylsila-loxy) -xanthen-9-one (91 mg, 0.2 mmol) in tetrahydrofuran (10 mL), and the container was covered with aluminum foil. The mixture was further stirred at the same temperature for 1 hour. To the reaction solution, 2 N HC1 (5 mL) was stirred for 10 minutes. The reaction solution is diluted with saturated aqueous NaHPO solution, extracted with ethyl acetate (3 X 15 mL), and washed with saturated brine.

2 4 twenty four

浄して無水 Na SOで乾燥させた。有機溶媒を留去し、得られた残渣をシリカゲルクロ  Clean and dry with anhydrous Na 2 SO 4. The organic solvent was distilled off, and the resulting residue was

2 4  twenty four

マトグラフィ一にて精製 (溶出溶媒:ジクロルメタン/メタノール(9:1))し、オレンジ色の 固体状の化合物 15 35 mg (収率 42%)を得た。  Purification by matrix chromatography (elution solvent: dichloromethane / methanol (9: 1)) gave 15 35 mg of orange solid compound (yield 42%).

JH NMR (300 MHz,メタノール— d ) δ 7.37 (s, 1H), 7.32 (s, 2H), 7.00 (d, 2H, J = 9. J H NMR (300 MHz, methanol—d) δ 7.37 (s, 1H), 7.32 (s, 2H), 7.00 (d, 2H, J = 9.

4  Four

0), 6.56-6.52 (m, 4H), 3.79 (s, 3H), 3.68—3.60 (m, 4H), 2.07—1.99 (m, 4H); HRMS ( ESI-MS) [M-H]" calcd for C H N O 414.1342, found 414.1332.  0), 6.56-6.52 (m, 4H), 3.79 (s, 3H), 3.68—3.60 (m, 4H), 2.07—1.99 (m, 4H); HRMS (ESI-MS) [MH] ”calcd for CHNO 414.1342, found 414.1332.

25 20 1 5  25 20 1 5

[0028] (F)化合物 16  [0028] (F) Compound 16

化合物 15 (62 mg, 0.15 mmol)を 1 N NaOH (10 mL)に溶かし 2時間還流した。反応 溶液を 2 N HC1で中和し、酢酸ェチル (3 X 15 mL)にて抽出し、飽和食塩水で洗浄し て無水 Na SOで乾燥させた。有機溶媒を留去し、得られた残渣をシリカゲルクロマト  Compound 15 (62 mg, 0.15 mmol) was dissolved in 1 N NaOH (10 mL) and refluxed for 2 hours. The reaction solution was neutralized with 2 N HC1, extracted with ethyl acetate (3 × 15 mL), washed with saturated brine, and dried over anhydrous Na 2 SO 4. The organic solvent was distilled off, and the resulting residue was

2 4  twenty four

グラフィ一にて精製 (溶出溶媒:ジクロルメタン/メタノール(8:2))し、オレンジ色の固 体状の化合物 16 49 mg (収率 90%)を得た。  Purification by GRAPHI (elution solvent: dichloromethane / methanol (8: 2)) gave 1649 mg (yield 90%) of an orange solid compound.

1H NMR (300 MHz,メタノーノレ— d ) δ 7.82 (d, 1H, J = 1.1), 7.75 (dd, 1H, J = 7.7, 1.  1H NMR (300 MHz, methanol-d) δ 7.82 (d, 1H, J = 1.1), 7.75 (dd, 1H, J = 7.7, 1.

4  Four

3), 7.21 (d, 1H, J = 7.9), 7.02 (d, 2H, J = 9.0), 6.56-6.51 (m, 4H), 3.79 (s, 3H); HR MS (ESI-MS) [M-H]" calcd for C H O 361.0712, found 361.0704.  3), 7.21 (d, 1H, J = 7.9), 7.02 (d, 2H, J = 9.0), 6.56-6.51 (m, 4H), 3.79 (s, 3H); HR MS (ESI-MS) (MH ] "calcd for CHO 361.0712, found 361.0704.

21 13 6  21 13 6

[0029] (G)化合物 17  [0029] (G) Compound 17

よく乾燥した容器に化合物 16 (36 mg, 0.10 mmol) ert-ブタノール(5 mL)に溶かし 、アルゴン雰囲気下で Boc 0 (0.11 mL, 0.50 mmol)と DMAP (18 mg, 0.15 mmol)を加  Dissolve Compound 16 (36 mg, 0.10 mmol) ert-butanol (5 mL) in a well-dried container and add Boc 0 (0.11 mL, 0.50 mmol) and DMAP (18 mg, 0.15 mmol) under an argon atmosphere.

2  2

えた。室温にて撹拌しつつオーバーナイトで反応させた。反応溶液を水で希釈した 後、酢酸ェチル (3 X 5 mL)にて抽出し、飽和食塩水で洗浄して無水 Na SOで乾燥さ Yeah. The reaction was carried out overnight with stirring at room temperature. The reaction solution was diluted with water Then, extract with ethyl acetate (3 X 5 mL), wash with saturated brine, and dry over anhydrous Na SO.

2 4 せた。有機溶媒を留去し、得られた残渣をシリカゲルクロマトグラフィーにて精製 (溶 出溶媒:ジクロルメタン/メタノール(9:1))し、オレンジ色の固体状の化合物 17 12 mg ( 収率 29%)を得た。  2 4 The organic solvent was distilled off, and the resulting residue was purified by silica gel chromatography (eluent: dichloromethane / methanol (9: 1)) to give an orange solid compound 17 12 mg (yield 29%) Got.

1H NMR (300 MHz,メタノーノレ— d ) δ 7.79-7.77 (m, 2H), 7.33 (d, 1H, J = 8.3), 6.94  1H NMR (300 MHz, methanol-d) δ 7.79-7.77 (m, 2H), 7.33 (d, 1H, J = 8.3), 6.94

4  Four

(d, 2H, J = 9.2), 6.56-6.50 (m, 4H), 3.80 (s, 3H); HRMS (ESI-MS) [M+H]+ calcd for C H O 419.1495, found 419.1489. (d, 2H, J = 9.2), 6.56-6.50 (m, 4H), 3.80 (s, 3H); HRMS (ESI-MS) [M + H] + calcd for CHO 419.1495, found 419.1489.

25 23 6  25 23 6

[0030] 例 4 :蛍光特性  [0030] Example 4: Fluorescence properties

各化合物の量子収率は、 490 nmにおける吸光度が 0.02以下となるように、 pH 7.4 (6 CF類については pH 9.0)の 0.1Mリン酸緩衝液に溶解し、 0.1N NaOH水溶液中のフ ルォレセインを対照(蛍光量子収率 = 0.85)として、相対法により決定した。  The quantum yield of each compound is dissolved in 0.1M phosphate buffer at pH 7.4 (pH 9.0 for 6CFs) so that the absorbance at 490 nm is 0.02 or less, and fluorescein in 0.1N NaOH aqueous solution. Was determined by a relative method as a control (fluorescence quantum yield = 0.85).

[表 2]  [Table 2]

Figure imgf000015_0002
Figure imgf000015_0002

[0031] 例 5 :化合物 19の合成  [0031] Example 5: Synthesis of Compound 19

[化 7]  [Chemical 7]

Figure imgf000015_0001
化合物 18は J. Am. Chem. So , 123, pp.2530-2536(2001)に記載の方法で合成し た。
Figure imgf000015_0001
Compound 18 was synthesized by the method described in J. Am. Chem. So, 123, pp.2530-2536 (2001).

化合物 18をメタノール溶解し、数滴の硫酸をカ卩え、 20時間還流した。ついで、反応 液を氷中に注ぎ入れ、酢酸ェチルにて抽出し、無水 Na SOで乾燥させた。有機溶媒  Compound 18 was dissolved in methanol, a few drops of sulfuric acid were added, and the mixture was refluxed for 20 hours. Next, the reaction solution was poured into ice, extracted with ethyl acetate, and dried over anhydrous Na 2 SO 4. Organic solvent

2 4  twenty four

を留去し、得られた残渣をシリカゲルクロマトグラフィーにて精製し、メタノール/ジクロ ルメタンにて再結晶して化合物 19を得た。 H NMR (300 MHz, DMSO— d ): δ 3.63 (s, 3H); 6.30 (br, 2H); 6.84 (m, 4H); 7.76 (m The residue was purified by silica gel chromatography and recrystallized from methanol / dichloromethane to obtain Compound 19. H NMR (300 MHz, DMSO— d): δ 3.63 (s, 3H); 6.30 (br, 2H); 6.84 (m, 4H); 7.76 (m

6  6

, 2H); 8.06 (m, 2H); 8.30 (m, IH); 8.89 (s, IH); 11.04 (br, IH). HRMS (ESI+): calcd for M++1, 397.107; found, 397.105. Mp: 325°C dec. Anal. Calcd for C H O -0.75  , 2H); 8.06 (m, 2H); 8.30 (m, IH); 8.89 (s, IH); 11.04 (br, IH) .HRMS (ESI +): calcd for M ++ 1, 397.107; found, 397.105. Mp: 325 ° C dec. Anal. Calcd for CHO -0.75

25 16 5 25 16 5

H O: N; 0, C; 73.25, H; 4.30. Found: N, 0; C; 73.43, H; 4.37. H O: N; 0, C; 73.25, H; 4.30. Found: N, 0; C; 73.43, H; 4.37.

2  2

[0032] 例 6 :化合物 11、 17、及び 19、並びに 4-メトキシカルボ-ルフルォレセインの蛍光量子 収率とベンゼン環部位の還元電位の関係  [0032] Example 6: Relationship between Fluorescence Quantum Yield of Compounds 11, 17, and 19, and 4-Methoxycarbo-fluorescein and Reduction Potential of Benzene Ring Site

[表 3] [Table 3]

Figure imgf000016_0001
Figure imgf000016_0001

[0033] 化合物 11、 17、及び 19、並びに 4-メトキシカルボ-ルフルォレセインの蛍光量子収 率とベンゼン環部位の還元電位の関係を上記の表 3に示した。上記のベンゼン環部 位の還元電位は、 A、 B、及び Cについてはァセトニトリル中で、 Dについては水溶液 中で飽和カロメロ電極 (SCE)を参照電極として測定した値である。 [0033] Table 3 shows the relationship between the fluorescence quantum yields of compounds 11, 17, and 19, and 4-methoxycarbo-fluorescein and the reduction potential of the benzene ring moiety. The reduction potential of the benzene ring moiety is a value measured in acetonitrile with A, B, and C, and in D aqueous solution with a saturated calomel electrode (SCE) as a reference electrode.

4-メトキシカルボ-ルフルォレセインの蛍光量子収率(0.203)〖こ対し、化合物 19の 蛍光量子収率は高 ヽ(0.673)。両ィ匕合物のベンゼン環部位の還元電位の高低も同 様の関係にあった。これらの結果から、電子密度が高く還元されにくい化合物は励起 蛍光団からの光誘起電子移動 (Donor- Excited Photoinduced Electron Transfer; d- P eT)を起こしにくく(Petァクセプターになりにくく)、高蛍光量子収率となることを示すも のと考えられた。  The fluorescence quantum yield of compound 19 is high (0.673), compared to the fluorescence quantum yield (0.203) of 4-methoxycarbofluorescein. The level of reduction potential at the benzene ring site of both compounds was similar. From these results, compounds with high electron density and which are not easily reduced are unlikely to cause photo-induced electron transfer (d-PeT) from the excited fluorophore (difficult to become a pet acceptor) and have high fluorescence quantum. This was considered to indicate the yield.

[0034] 別のベンゼン環部位の例として、 4_カルボキシァ-ソールおよび 3_カルボキシァ- ノールのメチルエステル体 (A及び B)についてその還元電位を確認すると、それぞ れ -2.54V、 -2.34Vであり、化合物 19のベンゼン環部位の 2-メトキシカルボ-ルナフタ レン (C)の還元電位より低ぐより PeTァクセプターになりにくいと考えられた。 4-カル ボキシァ-ソールおよび 3-カルボキシァ-ソールをベンゼン環部位として有する化合 物 12及び 16のエステル体の蛍光量子収率はそれぞれ 0.842及び 0.558であり、 6-カル ボキシフルォレセインメチルエステルの蛍光量子収率より高い。このようにして、実質 的に高 、蛍光性になるようにベンゼン環に低 、還元電位を与える置換基の組合わせ を選択することができることがわ力つた。化合物 12及び 16は高量子収率の蛍光ラベ ル化剤として好適である。 [0034] As another example of the benzene ring site, the reduction potentials of methyl ester of 4_carboxyl-sol and 3_carboxyl-anol (A and B) were confirmed to be -2.54V and -2.34V, respectively. It was thought that it was less likely to be a PeT acceptor than the reduction potential of 2-methoxycarbo-naphthalene (C) at the benzene ring site of compound 19. 4-cal The fluorescent quantum yields of the esters of compounds 12 and 16 having boxyl-sole and 3-carboxyl-sole as the benzene ring moiety are 0.842 and 0.558, respectively, and the fluorescent quantum yield of 6-carboxyfluorescein methyl ester is Higher than rate. In this way, it was found that a combination of substituents that give a reduction potential to the benzene ring so as to be substantially high and fluorescent can be selected. Compounds 12 and 16 are suitable as fluorescent labeling agents with high quantum yield.

例 7:スクシンィミジルエステル(SE)類の合成 Example 7: Synthesis of succinimidyl esters (SE)

[化 8] [Chemical 8]

3 eq. NHS 3 eq. NHS

3 eq. WSCD  3 eq. WSCD

- D 2 t -D 2 t

Figure imgf000018_0001
Figure imgf000018_0001

10 eq. NHS 10 eq. NHS

10 eq. WSCD  10 eq. WSCD

DMF  DMF

r. t., 1 h  r. t., 1 h

18%  18%

16(47b) 化合物 4(2la)、化合物 8(2lb)、化合物 I2(47a)、化合物 I6(47b)、それぞれ l mmol、 N -ヒドロキシスクシンイミド(NHS) 2、 3又は 10 mmolを無水ジメチルホルムアミド 5 mL に溶解し、これらの溶液に 2、 3又は 10 mmolの水溶性カルボジイミド(WSCD: N-(3-ジ メチルァミノプロピル)- Ν'-ェチルカルポジイミド)を氷冷下カ卩え、 0。Cで 1又は 2時間反 応させた。反応後リン酸水溶液を添加し、塩化メチレンで抽出して乾燥した後。溶媒 を減圧留去して目的のスクシンィミジルエステル体を得た。必要に応じてシリカゲル力 ラムにより目的物の精製を行った。 16 (47b) Compound 4 (2la), Compound 8 (2lb), Compound I2 (47a), Compound I6 (47b), l mmol, N-hydroxysuccinimide (NHS) 2, 3 or 10 mmol each in anhydrous dimethylformamide 5 mL Into these solutions, add 2, 3 or 10 mmol of water-soluble carbodiimide (WSCD: N- (3-dimethylaminopropyl) -Ν'-ethyl carpositimide) under ice-cooling. . C for 1 or 2 hours. After the reaction, an aqueous phosphoric acid solution was added, extracted with methylene chloride and dried. The solvent was distilled off under reduced pressure to obtain the desired succinimidyl ester. If necessary, the target product was purified using a silica gel force ram.

[0037] 21aSE [0037] 21aSE

JH NMR (300 MHz,メタノール— d ) δ 8.28 (dd, 1H, J = 8.2, 1.8), 8.02 (d, 1H, J = 1. J H NMR (300 MHz, methanol—d) δ 8.28 (dd, 1H, J = 8.2, 1.8), 8.02 (d, 1H, J = 1.

4  Four

7), 7.74 (d, 1H, J = 8.2), 7.06 (d, 2H, J = 9.3), 6.77-6.73 (m, 4H), 2.89 (s, 4H), 2.1 9 (s, 3H); HRMS (ESト MS) [M+H]+ calcd for C H NO + 444.1083, found 444.1117. 7), 7.74 (d, 1H, J = 8.2), 7.06 (d, 2H, J = 9.3), 6.77-6.73 (m, 4H), 2.89 (s, 4H), 2.1 9 (s, 3H); HRMS (ES MS) [M + H] + calcd for CH NO + 444.1083, found 444.1117.

25 18 7  25 18 7

21bSE  21bSE

JH NMR (300 MHz,メタノール— d ) δ 8.26 (s, 1H), 8.19 (d, 1H, J = 9.2), 7.52 (d, 1 J H NMR (300 MHz, methanol—d) δ 8.26 (s, 1H), 8.19 (d, 1H, J = 9.2), 7.52 (d, 1

4  Four

H, J = 7.9), 7.06 (d, 2H, J = 9.0), 6.77-6.73 (m, 4H), 2.94 (s, 4H), 2.17 (s, 3H); HR MS (ESI-MS) [M+H]+ calcd for C H NO + 444.1083, found 444.1041. H, J = 7.9), 7.06 (d, 2H, J = 9.0), 6.77-6.73 (m, 4H), 2.94 (s, 4H), 2.17 (s, 3H); HR MS (ESI-MS) (M + H] + calcd for CH NO + 444.1083, found 444.1041.

25 18 7  25 18 7

[0038] 47aSE  [0038] 47aSE

JH NMR (300 MHz, CD CN) δ 8.37 (dd, 1H, J = 8.8, 2.2), 7.97 (d, 1H, J = 2.2), 7. J H NMR (300 MHz, CD CN) δ 8.37 (dd, 1H, J = 8.8, 2.2), 7.97 (d, 1H, J = 2.2), 7.

3  Three

39 (d, 1H, J = 8.8), 7.03 (d, 2H, J = 9.5), 6.60—6.57 (m, 4H), 3.82 (s, 3H), 2.83(s, 4 H); HRMS (ESI-MS) [M+H]+ calcd for C H NO + 460.1032, found 460.0989. 39 (d, 1H, J = 8.8), 7.03 (d, 2H, J = 9.5), 6.60—6.57 (m, 4H), 3.82 (s, 3H), 2.83 (s, 4 H); HRMS (ESI- MS) [M + H] + calcd for CH NO + 460.1032, found 460.0989.

25 17 8  25 17 8

47bSE  47bSE

JH NMR (300 MHz, CD CN) δ 7.94 (dd, 1H, J = 7.9, 1.5), 7.87 (d, 1H, J = 1.5), 7. J H NMR (300 MHz, CD CN) δ 7.94 (dd, 1H, J = 7.9, 1.5), 7.87 (d, 1H, J = 1.5), 7.

3  Three

44 (d, 1H, J = 7.9), 7.01 (d, 2H, J = 9.7), 6.58-6.55 (m, 4H), 3.79 (s, 3H), 2.89(s, 4 H); HRMS (ESI-MS) [M+H]+ calcd for C H NO + 460.1032, found 460.1009. 44 (d, 1H, J = 7.9), 7.01 (d, 2H, J = 9.7), 6.58-6.55 (m, 4H), 3.79 (s, 3H), 2.89 (s, 4 H); HRMS (ESI- MS) [M + H] + calcd for CH NO + 460.1032, found 460.1009.

25 17 8  25 17 8

[0039] 例 8 :本発明の蛍光ラベル化剤を用いた BSAの蛍光修飾  [0039] Example 8: Fluorescence modification of BSA using the fluorescent labeling agent of the present invention

ゥシ血清アルブミン (BSA) 15 mgを 500 μ Lの 100 mmol/Lホウ酸バッファー(ρΗ 9.0) に溶解し、ここに本発明の蛍光ラベル化剤の 20 mMのジメチルホルムアミド溶液 50 μ Lを攪拌しながら添加した。そのまま室温で 1.5時間反応させた後、これを 1.5 gのセ フアデックス G25により精製した。溶離液は 1 X PBS (100 mmol/L NaCl、 40 mmol/L N aPi)を用いた。図 1には本発明の蛍光ラベル化剤でラベルイ匕された BSAの吸収スぺ クトルを示し、図 2には本発明の蛍光ラベル化剤でラベルイ匕された BSAの蛍光スぺク トル (励起波長: 490 nm)を示した。図に示した結果から、本発明の蛍光ラベル化剤に より BSAの高蛍光性修飾が可能であることが示された。 Dissolve 15 mg of urine serum albumin (BSA) in 500 μL of 100 mmol / L borate buffer (ρΗ9.0), and stir 50 μL of 20 mM dimethylformamide solution of the fluorescent labeling agent of the present invention. While adding. The mixture was allowed to react at room temperature for 1.5 hours, and then purified with 1.5 g of Sephadex G25. The eluent used was 1 × PBS (100 mmol / L NaCl, 40 mmol / LN aPi). Figure 1 shows the absorption spectrum of BSA labeled with the fluorescent labeling agent of the present invention, and Fig. 2 shows the fluorescence spectrum of BSA labeled with the fluorescent labeling agent of the present invention. Torr (excitation wavelength: 490 nm). From the results shown in the figure, it was shown that the fluorescent labeling agent of the present invention enables highly fluorescent modification of BSA.

産業上の利用可能性 Industrial applicability

本発明の蛍光ラベル化剤は、カルボキシフルォレセインで見られたラベル化による 蛍光量子収率の低下を克服しており、高い量子収率を有する蛍光ラベル化剤として タンパク質は有機化合物などのラベル化に有用である。  The fluorescent labeling agent of the present invention overcomes the decrease in the fluorescence quantum yield due to the labeling observed with carboxyfluorescein, and as a fluorescent labeling agent having a high quantum yield, proteins such as organic compounds Useful for labeling.

Claims

請求の範囲 下記の式(I): Claims Formula (I) below: [化 1]  [Chemical 1]
Figure imgf000021_0001
Figure imgf000021_0001
(式中、
Figure imgf000021_0002
及び R4はそれぞれ独立に水素原子又は一価の置換基を示すが 、これらのうち少なくとも 1個は、被ラベル化物質に共有結合を介して結合可能な反 応性官能基を示し; R5は水素原子、カルボキシル基またはスルホン酸基以外の一価 の基を示し; R6及び R7はそれぞれ独立に水素原子又はハロゲン原子を示し; R8は水 素原子、アルキルカルボ-ル基、又はアルキルカルボ-ルォキシメチル基を示し、た だし、
Figure imgf000021_0003
及び R5の組み合わせは、式 (I)で表される化合物が被ラベル 化物質に共有結合した後、実質的に高い蛍光性になるように、それらが結合するべ ンゼン環に低 1、還元電位を与える組み合わせである)で表される蛍光ラベル化剤。
(Where
Figure imgf000021_0002
And R 4 each independently represent a hydrogen atom or a monovalent substituent, and at least one of these represents a reactive functional group that can be bonded to the labeled substance via a covalent bond; R 5 represents Represents a monovalent group other than a hydrogen atom, a carboxyl group or a sulfonic acid group; R 6 and R 7 each independently represent a hydrogen atom or a halogen atom; R 8 represents a hydrogen atom, an alkyl carbo group or an alkyl Represents a carbo-loxymethyl group, provided that
Figure imgf000021_0003
And the combination of R 5 is low in the benzene ring to which the compound represented by the formula (I) is covalently bonded to the labeling substance and then becomes substantially highly fluorescent, and is reduced by 1, A fluorescent labeling agent represented by a combination that gives an electric potential).
[2] R5がアルキル基又はアルコキシ基である、請求項 1に記載の蛍光ラベル化剤。 [2] R 5 is an alkyl group or an alkoxy group, a fluorescent labeling agent according to claim 1. [3] 該反応性官能基が、カルボキシル基又はその反応性誘導体である請求項 1又は 2に 記載の蛍光ラベル化剤。 [3] The fluorescent labeling agent according to claim 1 or 2, wherein the reactive functional group is a carboxyl group or a reactive derivative thereof. [4] 該反応性官能基が活性エステル基である請求項 3に記載の蛍光ラベル化剤。 4. The fluorescent labeling agent according to claim 3, wherein the reactive functional group is an active ester group. [5] 被ラベルイ匕物質力 Sタンパク質、核酸、又は脂質である請求項 1な 、し 4の 、ずれか 1 項に記載の蛍光ラベル化剤。 [5] The fluorescent labeling agent according to any one of claims 1 to 4, which is S protein, nucleic acid, or lipid. [6] 被ラベルイ匕物質を蛍光ラベルイ匕する方法であって、請求項 1な 、し 5の 、ずれか 1項 に記載の蛍光ラベル化剤と被ラベル化物質とを反応させる工程を含む方法。 [6] A method for fluorescently labeling a substance to be labeled, comprising the step of reacting the fluorescent labeling agent according to any one of claims 1 and 5 and the labeling substance. .
PCT/JP2005/014983 2004-08-17 2005-08-17 Fluorescent labeling agents Ceased WO2006019105A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006531814A JP5068535B2 (en) 2004-08-17 2005-08-17 Fluorescent labeling agent

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60198604P 2004-08-17 2004-08-17
US60/601,986 2004-08-17

Publications (1)

Publication Number Publication Date
WO2006019105A1 true WO2006019105A1 (en) 2006-02-23

Family

ID=35907490

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2005/014983 Ceased WO2006019105A1 (en) 2004-08-17 2005-08-17 Fluorescent labeling agents

Country Status (2)

Country Link
JP (1) JP5068535B2 (en)
WO (1) WO2006019105A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011149109A1 (en) 2010-05-25 2011-12-01 三菱レイヨン株式会社 Fluorescent substrate for detection of enzymatic activity of nitrile-related enzyme
CN103224483A (en) * 2013-05-06 2013-07-31 西北工业大学 Fluorescent compound used for labeling oligosaccharide, and preparation method thereof
US9051597B2 (en) 2010-05-25 2015-06-09 Mitsubishi Rayon Co., Ltd. Fluorescent substrate for detection of enzymatic activity of nitrile-related enzyme
US9657048B2 (en) 2014-08-04 2017-05-23 Auburn University Enantiomers of the 1′,6′-isomer of neplanocin A
CN106749153A (en) * 2016-12-19 2017-05-31 华东理工大学 The specificity fluorescent probe of nitroreductase and its preparation and the application for cancer target fluorescence imaging and monitoring tumor hypoxia degree
CN113999247A (en) * 2021-11-03 2022-02-01 安徽理工大学 A kind of preparation method of fluorescent ketone reagent

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004005917A1 (en) * 2002-07-08 2004-01-15 Daiichi Pure Chemicals Co., Ltd. Fluorescent probe

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004005917A1 (en) * 2002-07-08 2004-01-15 Daiichi Pure Chemicals Co., Ltd. Fluorescent probe

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
FEDIN A.V. ET AL: "Crystallographic characteristics of 2,3,7-trihydroxy-6-fluorone", KRISTALLOGRAFIYA, vol. 20, no. 1, 1975, pages 163 - 166, XP002995043 *
FOGL J. E AL: "Acid-base equilibriums in solutions of 2,6,7-trihydroxy-3H-xanhen-3-one derivatives", SBORNIK VYSOKE SKOLY CHEMICKO-TECHNOLOGICKE V PRAZE, H: ANALYTICKA CHEMIE, vol. H-16, 1981, pages 17 - 39, XP002995044 *
KULT K. ET AL: "Optimization of the spectrophotometric determination of germanium with 2-hydroxy-3-carboxyphenylfluorone in the presence of Septonex", SBORNIK VYSOKE SKOLY CHEMICKO-TECHNOLOGICKE V PRAZE H: ANALYTICKA CHEMIE, vol. H-21, 1986, pages 71 - 81, XP002995045 *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011149109A1 (en) 2010-05-25 2011-12-01 三菱レイヨン株式会社 Fluorescent substrate for detection of enzymatic activity of nitrile-related enzyme
US8697383B2 (en) 2010-05-25 2014-04-15 Mitsubishi Rayon Co., Ltd. Fluorescent substrate for detection of enzymatic activity of nitrile-related enzyme
US9051597B2 (en) 2010-05-25 2015-06-09 Mitsubishi Rayon Co., Ltd. Fluorescent substrate for detection of enzymatic activity of nitrile-related enzyme
CN103224483A (en) * 2013-05-06 2013-07-31 西北工业大学 Fluorescent compound used for labeling oligosaccharide, and preparation method thereof
US9657048B2 (en) 2014-08-04 2017-05-23 Auburn University Enantiomers of the 1′,6′-isomer of neplanocin A
US10227373B2 (en) 2014-08-04 2019-03-12 Auburn University Enantiomers of the 1′,6′-isomer of neplanocin A
US10787478B2 (en) 2014-08-04 2020-09-29 Auburn University Enantiomers of the 1′,6′-isomer of neplanocin A
CN106749153A (en) * 2016-12-19 2017-05-31 华东理工大学 The specificity fluorescent probe of nitroreductase and its preparation and the application for cancer target fluorescence imaging and monitoring tumor hypoxia degree
CN106749153B (en) * 2016-12-19 2020-10-09 华东理工大学 Specific fluorescent probe of nitroreductase, preparation thereof and application thereof in tumor targeted fluorescence imaging and monitoring of tumor hypoxia degree
CN113999247A (en) * 2021-11-03 2022-02-01 安徽理工大学 A kind of preparation method of fluorescent ketone reagent

Also Published As

Publication number Publication date
JPWO2006019105A1 (en) 2008-05-08
JP5068535B2 (en) 2012-11-07

Similar Documents

Publication Publication Date Title
US9714260B2 (en) Asymmetrical Si rhodamine and rhodol synthesis
JP5526124B2 (en) Near-infrared fluorescent compound
EP2734518B1 (en) Complexing agents and corresponding lanthanide complexes
KR100938491B1 (en) Water soluble photochromic compound for biomolecule labeling and biomolecule detection method using the same
JP4899046B2 (en) New luciferin derivatives
US9701667B2 (en) Coumarin-based fluorogenic agents and uses thereof for specific protein labelling
EP4382526A1 (en) Fluorescent dye, and preparation method therefor and use thereof
JP2025118805A (en) luminescent compounds
WO2005085811A1 (en) Fluorescent probes
WO2006019105A1 (en) Fluorescent labeling agents
Clavé et al. A universal and ready-to-use heterotrifunctional cross-linking reagent for facile synthetic access to sophisticated bioconjugates
JP5070057B2 (en) Novel fluorescent labeling compounds
CN105492575A (en) Electronically neutral metal complexes as biological labels
JP2018054434A (en) Method and kit for detecting compound containing formyl-dehydro-piperidine structure
JP2009014369A (en) Fluorescent reagent for labeling biomolecules
US7563902B2 (en) Chemiluminescent compounds and their use
JP6670502B2 (en) Development of ligand screening system for neurotransmitter receptor
JP4421692B2 (en) 1,2-Dioxetane derivative condensed with pyran ring, measuring reagent and measuring method using the derivative
JP4929461B2 (en) High Fluorescence Quantum Yield Hydrophobic Fluorescent Probe, Biopolymer Detection Method Using It, and Interaction Detection Method between Biopolymers
JP5360609B2 (en) Reagent for low oxygen environment measurement
FR3045053A1 (en) TRIAZAPYRIDINOPHANE WATER-SOLUBLE COMPLEXING AGENTS AND CORRESPONDING FLUORESCENT LANTHANIDE COMPLEXES
JP4421693B2 (en) 1,2-Dioxetane derivative condensed with furan ring, measuring reagent and measuring method using the derivative
Hirano et al. Modulation of intramolecular heterodimer-induced fluorescence quenching of tricarbocyanine dye for the development of fluorescent sensor
JP5310702B2 (en) Labeled compound and detection method using the same
JPWO2019022097A1 (en) Sulfonyl azidobenzoic acid derivative and its reactive derivative

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006531814

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase